-29.5%
MRNA vs VRSN
+27.7%
-57.2%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VRSN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -0.2% | +1.5% | +1.4% |
| 7D | -13.8% | -1.7% | -12.2% | -13.3% |
| 30D | -17.7% | +0.2% | -17.9% | -17.7% |
| 3M | +14.3% | +12.5% | +1.8% | +9.7% |
| 6M | +336.0% | +1.8% | +334.2% | +330.8% |
| YTD | +575.9% | +27.7% | +548.3% | +488.5% |
| 1Y | +724.4% | +26.2% | +698.2% | +621.5% |
| 3Y | +160.8% | +48.9% | +111.9% | +99.3% |
| All | -29.5% | +27.7% | -57.2% | -42.3% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSN.
Daily Out/Under-Performance
Portfolio return minus VRSN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VRSN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling